» Articles » PMID: 35529342

Rapid and Low-cost, and Disposable Electrical Sensor Using an Extended Gate Field-effect Transistor for Cardiac Troponin I Detection

Overview
Journal Biomed Eng Lett
Date 2022 May 9
PMID 35529342
Authors
Affiliations
Soon will be listed here.
Abstract

Field effect transistor (FET) biosensor is based on metal oxide field effect transistor that is gated by changes in the surface charges induced the reaction of biomolecules. In most cases of FET biosensor, FET biosensor is not being reused after the reaction; therefore, it is an important concept of investigate the biosensor with simplicity, cheap and reusability. However, the conventional cardiac troponin I (cTnI) sensing technique is inadequate owing to its low sensitivity and high operational time and cost. In this study, we developed a rapid and low-cost, and disposable electrical sensor using an extended gate field-effect transistor (EGFET) to detect cTnI, as a key biomarker for myocardiac infarction. We first investigated pH sensing characteristics according to the pH level, which provided a logarithmically linear sensitivity in the pH sensing buffer solution of approximately 57.9 mV/pH. Subsequently, we prepared a cTnI sample and monitored the reaction between cTnI and cTnI antibodies through the changes in the drain current and transfer curves. Our results showed that the EGFET biosensor could successfully detect the cTnI levels as well as the pH with low-cost and rapid detection.

Citing Articles

Magnetically controlled graphene field-effect transistor biosensor for highly sensitive detection of cardiac troponin I.

Zhu X, Cheng K, Ding Y, Liu H, Xie S, Cao Y Discov Nano. 2023; 18(1):106.

PMID: 37642818 PMC: 10465447. DOI: 10.1186/s11671-023-03886-6.

References
1.
Aviles R, Askari A, Lindahl B, Wallentin L, Jia G, Ohman E . Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med. 2002; 346(26):2047-52. DOI: 10.1056/NEJMoa013456. View

2.
Roongsritong C, Warraich I, Bradley C . Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest. 2004; 125(5):1877-84. DOI: 10.1378/chest.125.5.1877. View

3.
Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L . Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000; 343(16):1139-47. DOI: 10.1056/NEJM200010193431602. View

4.
Moser D, McKinley S, Dracup K, Chung M . Gender differences in reasons patients delay in seeking treatment for acute myocardial infarction symptoms. Patient Educ Couns. 2004; 56(1):45-54. DOI: 10.1016/j.pec.2003.11.011. View

5.
Cullen L, Parsonage W, Greenslade J, Lamanna A, Hammett C, Than M . Delta troponin for the early diagnosis of AMI in emergency patients with chest pain. Int J Cardiol. 2013; 168(3):2602-8. DOI: 10.1016/j.ijcard.2013.03.044. View